Company Information

CIN
Status
Date of Incorporation
20 February 2007
State / ROC
Hyderabad / ROC Hyderabad
Industry
allopathic pharmaceutical
Sub Category
Non-govt company
Last Balance Sheet
Last Annual Meeting
Paid Up Capital
200,000,000
Authorised Capital
200,000,000

Past Directors

Patents

Taste Masked Orally Disintegrating Composition Of Imatinib Mesylate And Process For The Preparation Thereof

The present invention provides a taste masked orally disintegrating composition, preferably an orally disintegrating tablet of Imatinib or pharmaceutically acceptable salt thereof, comprising a) Imatinib or pharmaceutically acceptable salts thereof, b) a taste-masking polymer, c) a super disintegrant and optionally ...

Dipyridamole And Acetyl Salicylic Acid Capsule Formulation

The present invention provides the pharmaceutical capsule formulation comprising the compound pellets consisting of Dipyridamole and Acetyl salicylic acid and the process for preparing the same.

Imatinib Mesilate Pharmaceutical Tablet

The present invention provides a pharmaceutical tablet, comprising Imatinib in an amount of 50-75%w/w of the total tablet weight and comprising atleast one pharmaceutically acceptable excipient without a binding agent and the process for preparation of the same.

Lansoprazole Orally Disintegrating Tablets

The present invention relates to an orally disintegrate tablet which comprises (i) the granules having an average particle diameter of more than 400µm which granules comprise a composition coated by an enteric coating layer comprising an enteric coating agent and viscosity imparting agent and (ii) an additive. ...

Stabilized Zolmitriptan Orally Disintegrating Tablet

The present invention relates to the orally disintegrating tablets of Zolmitriptan comprising the Zolmitriptan as an active ingredient and a stabilizer.

Pharmaceutical Compositions Of Dexlansoprazole

The present invention relates to Pharmaceutical capsule comprising the tablet, pellets or granules comprising (i) a core ii) the first drug layer comprising 30-90% of Dexlansoprazole of the total weight of the Dexlansoprazole filled into the capsules iii) a first sub coating layer iv) an extended release layer compr...

Stabilized Pharmaceutical Composition Of Levodopa, Carbidopa And Entacapone

The present invention relates to the stable pharmaceutical composition comprising levodopa, carbidopa, entacapone or pharmaceutically acceptable salts or hydrates thereof and a stabilizer. The invention also relates to the process of preparing said stable pharmaceutical composition.

Pharmaceutical Compositions Of Levodopa, Carbidopa And Entacapone

The present invention relates to the pharmaceutical composition comprising two discrete portions of the mixtures of levodopa, carbidopa and entacapone or pharmaceutically acceptable salts or hydrates thereof and the process for preparing the same.

Trademarks

Nlead

[Class : 5] Medicinal And Pharmaceutical Preparations; Veterinary And Sanitary Preparations